Liquidia ($LQDA) Insider Trading & Smart Money Activity
Liquidia Corporation ($LQDA) has 19 insider trades, 1 13F position change and 2 analyst ratings on file. In the last 12 months on the open market, no insider bought and 11 insiders sold ($40.03M), net -$40.03M.
- Insider buyers (12 mo)
- 0
- Insider sellers (12 mo)
- 11
- Net insider $ (12 mo)
- -$40.03M
- Congress trades (12 mo)
- 0
- 13F moves on file
- 1
- Analyst ratings on file
- 2
LQDA insider buying and selling by quarter
| Quarter | Insider buys | Insider sales | Congress buys / sales | 13F added / cut |
|---|---|---|---|---|
| Q1 2026 | 0 | 0 | 0 / 0 | 0 / 0 |
| Q2 2026 | 0 | 3 · $30.71M | 0 / 0 | 0 / 0 |
| Q3 2026 | 0 | 0 | 0 / 0 | 0 / 0 |
| Q4 2026 | 0 | 10 · $9.32M | 0 / 0 | 0 / 1 |
Insider buys and sales count open-market trades only (Form 4 codes P and S). Grants, option exercises and tax withholding are left out.
All LQDA insider, congress, 13F and analyst activity
| Date | Source | Who | Action | Shares | Value / amount | ΔOwn | 1W | 1M | 6M | Filing | Story |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 13F | Burney Co/ | Sold out | -53.01K sh | Read | |||||||
| Insider | Schundler RussellGeneral Counsel | Sell (Open-market sale) 10b5-1 | 13.69K sh | $389.95K | Read | ||||||
| Insider | Saggar RajeevChief Medical Officer | Sell (Open-market sale) 10b5-1 | 9.22K sh | $262.53K | Read | ||||||
| Insider | Moomaw ScottChief Commercial Officer | Sell (Open-market sale) 10b5-1 | 8.86K sh | $252.42K | Read | ||||||
| Insider | Krepp SarahChief Human Resource Officer | Sell (Open-market sale) 10b5-1 | 5.25K sh | $149.38K | Read | ||||||
| Insider | Khindri SanjeevChief Development Officer | Sell (Open-market sale) 10b5-1 | 1.10K sh | $31.36K | Read | ||||||
| Insider | Kaseta MichaelCFO and COO | Sell (Open-market sale) 10b5-1 | 18.94K sh | $539.35K | Read | ||||||
| Insider | Roger JeffsChief Executive Officer | Sell (Open-market sale) 10b5-1 | 32.74K sh | $932.55K | Read | ||||||
| Insider | Boyle DanaChief Accounting Officer | Sell (Open-market sale) 10b5-1 | 5.89K sh | $167.80K | Read | ||||||
| Insider | Adair JasonChief Business Officer | Sell (Open-market sale) 10b5-1 | 7.30K sh | $207.93K | Read | ||||||
| Insider | Bloch Stephen MDirector | Sell (Open-market sale) | 235.48K sh | $6.39M | +0.1% | — | |||||
| Analyst | B of A Securities | Lowers to hold | PT $79 | +5.4% | +15.6% | Read | |||||
| Insider | Stephen Bloch | Sell (Open-market sale) | 100K sh | $7.57M | -0.5% | +15.3% | — | ||||
| Analyst | BTIG | Reiterates to buy | PT $109 | -0.5% | +15.3% | Read | |||||
| Insider | Katherine Rielly-Gauvin | Buy (Grant or award) | 5.88K sh | +8.9% | +10.7% | — | |||||
| Insider | Paul Manning | Buy (Grant or award) | 5.88K sh | +8.9% | +10.7% | — | |||||
| Insider | Arthur Kirsch | Buy (Grant or award) | 5.88K sh | +8.9% | +10.7% | Read | |||||
| Insider | Joanna Horobin | Buy (Grant or award) | 5.88K sh | +8.9% | +10.7% | — | |||||
| Insider | Damian Degoa | Buy (Grant or award) | 5.88K sh | +8.9% | +10.7% | Read | |||||
| Insider | Stephen Bloch | Buy (Grant or award) | 5.88K sh | +8.9% | +10.7% | — | |||||
| Insider | Stephen Bloch | Sell (Open-market sale) | 85.06K sh | $6.08M | +5.1% | +8.3% | — | ||||
| Insider | Stephen Bloch | Sell (Open-market sale) | 242.27K sh | $17.06M | -0.8% | -0.6% | — |
1W / 1M / 6M = how LQDA moved from the trade or filing date.
Insider trading in LQDA: who is buying and selling
| Insider | Role | Trades | Open-market net | Shares held | Last trade |
|---|---|---|---|---|---|
| Schundler Russell | General Counsel | 1 | -$389.95K | Oct 12, 2026 | |
| Saggar Rajeev | Chief Medical Officer | 1 | -$262.53K | Oct 12, 2026 | |
| Moomaw Scott | Chief Commercial Officer | 1 | -$252.42K | Oct 12, 2026 | |
| Krepp Sarah | Chief Human Resource Officer | 1 | -$149.38K | Oct 12, 2026 | |
| Khindri Sanjeev | Chief Development Officer | 1 | -$31.36K | Oct 12, 2026 | |
| Kaseta Michael | CFO and COO | 1 | -$539.35K | Oct 12, 2026 | |
| Roger Jeffs | Chief Executive Officer | 1 | -$932.55K | Oct 12, 2026 | |
| Boyle Dana | Chief Accounting Officer | 1 | -$167.80K | Oct 12, 2026 | |
| Adair Jason | Chief Business Officer | 1 | -$207.93K | Oct 12, 2026 | |
| Bloch Stephen M | Director | 1 | -$6.39M | Oct 5, 2026 | |
| Stephen Bloch | 4 | -$30.71M | Jun 22, 2026 | ||
| Katherine Rielly-Gauvin | 1 | — | Jun 16, 2026 | ||
| Paul Manning | 1 | — | Jun 16, 2026 | ||
| Arthur Kirsch | 1 | — | Jun 16, 2026 | ||
| Joanna Horobin | 1 | — | Jun 16, 2026 | ||
| Damian Degoa | 1 | — | Jun 16, 2026 |
Institutions moving LQDA (13F)
Analyst ratings on LQDA
Frequently asked questions
Are LQDA insiders buying or selling?
Over the last 12 months 0 insiders made 0 open-market purchases worth $0 and 11 insiders made 13 open-market sales worth $40.03M, a net -$40.03M.
What is the latest insider trade in LQDA?
Schundler Russell, General Counsel filed a sell (open-market sale) of 13.69K sh worth $389.95K on Oct 12, 2026.
Which institutions changed their LQDA positions?
Recent 13F filers moving the stock include Burney Co/.
Other drug manufacturers - specialty & generic stocks
Data comes from public SEC Form 4 and 13F filings and STOCK Act disclosures. Dates are the trade or filing date reported. This page is for research only and is not investment advice.
Get a text when insiders, Congress or big funds trade a stock.
Free. Reply STOP anytime.